AAO 2025: The outcomes of the VERONA and DAVIO-2 studies set up continued phase 3 researchBySydney M Crago,Ashkan Abbey, MD, FASRS, FAAOOctober 18th 2025Data suggests the candidate can reduce the number of injections and treatment burden for patients